KALA - KALA BIO, Inc.
3.42
-0.010 -0.292%
Share volume: 31,933
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$3.43
-0.01
0.00%
Summary score
20%
Profitability
8%
Dept financing
16%
Liquidity
75%
Performance
20%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-34.84%
Return on assets
-14.21%
Return on sales
-1742.72%
Return on invested capital
86.52%
Total debt ratio
46.99%
Debt ratio change over timeo
0%
Current Ratio
9.05%
Quick Ratio
8.32%
Cash Position Ratio
8.28%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-40.34%
Return on assets
-10.73%
Return on sales
-1907.92%
Return on invested capital
-77.97%
Total debt ratio
61.69%
Debt ratio change over timeo
0%
Current Ratio
8.58%
Quick Ratio
8.29%
Cash Position Ratio
6.95%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-18.08%
Return on assets
-8.67%
Return on sales
-2554.62%
Return on invested capital
-73.9%
Total debt ratio
47.48%
Debt ratio change over time
0%
Current Ratio
11.63%
Quick Ratio
11.29%
Cash Position Ratio
7.56%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
Long-term ratios | KALA | LLY | JNJ | NVO |
---|---|---|---|---|
Return on equity | -34.84% | 17.45% | 4.69% | 19.89% |
Return on assets | -14.21% | 3.37% | 3.35% | 11.41% |
Return on sales | -1742.72% | 23.96% | 25.96% | 42.05% |
Return on invested capital | 86.52% | 5.2% | 4.37% | -272.99% |
Profitability | 25% | 45% | 30% | 75% |
Total debt ratio | 46.99% | 77% | 57.66% | 53.92% |
Debt ratio change over time | 0% | 0% | 10.55% | 0% |
Dept financing | 15% | 25% | 44% | 18% |
Current Ratio | 8.58% | 1.16% | 1.27% | 1.05% |
Quick Ratio | 8.29% | 0.89% | 1.01% | 0.77% |
Cash Position Ratio | 6.95% | 0.17% | 0.53% | 0.31% |
Liquididy | 75% | 8% | 10% | 7% |
Short-term ratios | KALA | LLY | JNJ | NVO |
---|---|---|---|---|
Return on equity | -40.34% | 44.06% | 6.24% | 17.3% |
Return on assets | -10.73% | 3.88% | 3.22% | 9.33% |
Return on sales | -1907.92% | 27.04% | 24.93% | 40.02% |
Return on invested capital | -77.97% | 9.69% | 4.96% | -224.06% |
Profitability | 0% | 77% | 41% | 60% |
Total debt ratio | 61.69% | 91.8% | 61.39% | 55.88% |
Debt ratio change over time | 0% | 0% | 12.93% | 0% |
Dept financing | 17% | 25% | 42% | 15% |
Current Ratio | 8.58% | 1.16% | 1.27% | 1.05% |
Quick Ratio | 8.29% | 0.89% | 1.01% | 0.77% |
Cash Position Ratio | 6.95% | 0.17% | 0.53% | 0.31% |
Liquididy | 75% | 7% | 9% | 6% |